Duha Shellah

Dr. Duha Shellah

The Researchist, Gaza, Palestinian Territory, Occupied
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2020 in Global Public Health
Verified
Journal Article
Closed access
MKMohammed Khaldi
Mohammed Khaldi
RKRasha Kaloti
Rasha Kaloti
Duha ShellahDuha Shellah
Duha Shellah
ABAisha Al Basuoni
Aisha Al Basuoni
HMHamza Meghari
Hamza Meghari
As the COVID-19 pandemic spreads, concerns are particularly serious in conflict and humanitarian settings. Tackling the pandemic in those countries is challenging due to the fragility of socioeconomic and health systems. Palestine is one of those countries that is facing compounding challenges, instability, fragility, living conditions, poverty, and mobility, all of which are caused by multifactorial etiology. The Pandemic shows triple tragedies; virus (COVID-19 Pandemic), ongoing Israeli occupation (Politics), and Intra-Palestinian divide (Policies). Yet, Palestine’s response to the pandemic is outperforming many countries in the region. The early preventative lockdown measures in the West Bank found effective and not overwhelming the already over-stretched health system. While in the Gaza Strip, the response was slow. Prisoners, labours, besieged people, socioeconomic-disadvantaged classes, and refugees were put at additional high risk. Nonetheless, measures taken were unconsolidated in both regions largely due to the political factors. A little collaboration and inter-agency task forces in preparedness and response was observed, and the mechanisms and governance remain ambiguous. A consolidated and evidence-based nation-wide plan is required, whereby state and non-state actors have a clear and transparent exit strategy. A new thinking approach to promote the public health system and evidence-informed policies in Palestine is an urgent national priority.

1 January 2022 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
SSSheikh Shoib
Sheikh Shoib
SJSana Javed
Sana Javed
RARoa Alamrawy
Roa Alamrawy
ANArif Nigar
Arif Nigar
Soumitra DasSoumitra Das
Soumitra Das
Miyuru ChandradasaMiyuru Chandradasa
Miyuru Chandradasa

4 July 2024 in The Lancet
Verified
Journal Article
Closed access
Duha ShellahDuha Shellah
Duha Shellah

22 January 2024 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
Duha ShellahDuha Shellah
Duha Shellah

25 October 2021 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
SSSheikh Shoib
Sheikh Shoib
AGApeksha Gupta
Apeksha Gupta
SSSheikh Mohd Saleem
Sheikh Mohd Saleem
Duha ShellahDuha Shellah
Duha Shellah
SJSana Javed
Sana Javed
JHJibril I.M. Handuleh
Jibril I.M. Handuleh

2 November 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
MCMatei-Alexandru Cozma
Matei-Alexandru Cozma
EDElena-Codruta Dobrică
Elena-Codruta Dobrică
PSPurva Shah
Purva Shah
Duha ShellahDuha Shellah
Duha Shellah
Mihnea-Alexandru GamanMihnea-Alexandru Gaman
Mihnea-Alexandru Gaman
Camelia DiaconuCamelia Diaconu
Camelia Diaconu
Introduction: Type 2 diabetes mellitus (T2DM) has been associated with higher rates and poorer prognosis of infections, mainly due to poor glycemic control, reduced response of T-cells and neutrophils, and impaired migration, phagocytosis, and chemotaxis of leukocytes. However, the impact of T2DM on acute cholangitis (AC) has not been assessed so far. Thus, we aimed to explore this association by means of a systematic review of the literature. Methods: This systematic review was carried out based on the recommendations stated in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched the PubMed/MEDLINE, Web of Science and SCOPUS databases to identify relevant publications depicting an association between T2DM and AC from the inception of these search services up to present. Results: We detected a total of 435 eligible records. After we applied the inclusion and exclusion criteria, a total of 14 articles were included in the present systematic review. Included manuscripts focused on the potential role of T2DM as a risk factor for the development of AC and on its contribution to a worse prognosis in AC, e.g., development of sepsis or other complications, the risk of AC recurrence and the impact on mortality. Conclusions: As compared to non-diabetic individuals, patients with T2DM have a higher risk of AC as a complication of choledocholithiasis or gallstone pancreatitis. Several oral hypoglycemic drugs used in the management of T2DM may also be involved in the onset of AC. Diabetic patients who suffer from AC have a higher likelihood of longer hospital stays and sepsis, as well as a higher risk of mortality and more severe forms of AC as compared to non-diabetic individuals.